Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) is a fully integrated global CDMO providing comprehensive development and cGMP manufacturing services for both small and large molecule pharmaceuticals. With facilities in Belgium, the United States, Japan, and India, the company offers platform technologies including oligonucleotide manufacturing, ADC conjugation, small molecule API synthesis, and aseptic fill-finish services. The Althea fill-finish site was acquired by PCI Pharma Services.
Small molecule API synthesis, oligonucleotide manufacturing, ADC conjugation, biologics manufacturing, aseptic fill-finish, corynex protein expression technology
4 sites worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.